Preparation of Pooled Human Platelet Lysate (pHPL) As an Efficient Supplement for Animal Serum-free Human Stem Cell Cultures

Overview

Journal J Vis Exp

Specialties Biology
General Medicine

Date 2009 Nov 3

PMID 19881465

Citations 71

Authors

Katharina Schallmoser

Dirk Strunk

Affiliations

Soon will be listed here.

Abstract

Platelet derived growth factors have been shown to stimulate cell proliferation efficiently in vivo(1,2) and in vitro. This effect has been reported for mesenchymal stromal cells (MSCs), fibroblasts and endothelial colony-forming cells with platelets activated by thrombin(3-5) or lysed by freeze/thaw cycles(6-14) before the platelet releasate is added to the cell culture medium. The trophic effect of platelet derived growth factors has already been tested in several trials for tissue engineering and regenerative therapy.(1,15-17) Varying efficiency is considered to be at least in part due to individually divergent concentrations of growth factors(18,19) and a current lack of standardized protocols for platelet preparation.(15,16) This protocol presents a practicable procedure to generate a pool of human platelet lysate (pHPL) derived from routinely produced platelet rich plasma (PRP) of forty to fifty single blood donations. By several freeze/thaw cycles the platelet membranes are damaged and growth factors are efficiently released into the plasma. Finally, the platelet fragments are removed by centrifugation to avoid extensive aggregate formation and deplete potential antigens. The implementation of pHPL into standard culture protocols represents a promising tool for further development of cell therapeutics propagated in an animal protein-free system.

Citing Articles

Assessment of Umbilical Cord Mesenchymal Stem Cell Cultivation Using Fetal Bovine Serum or Platelet Lysate.

Attaelmanan G, Khalil H Cureus. 2025; 17(1):e78044.

PMID: 40013174 PMC: 11862980. DOI: 10.7759/cureus.78044.

Heparin Differentially Regulates the Expression of Specific miRNAs in Mesenchymal Stromal Cells.

Oeller M, Schally T, Zimmermann G, Lauth W, Schallmoser K, Rohde E Int J Mol Sci. 2024; 25(23).

PMID: 39684301 PMC: 11641817. DOI: 10.3390/ijms252312589.

Evaluation of Human Platelet Lysate as an Alternative to Fetal Bovine Serum for Potential Clinical Applications of Stem Cells from Human Exfoliated Deciduous Teeth.

Yoon J, Vu H, Lee J, Shin J, Kim H, Lee H Cells. 2024; 13(10.

PMID: 38786069 PMC: 11120611. DOI: 10.3390/cells13100847.

Comparison between Platelet Lysate, Platelet Lysate Serum, and Fetal Bovine Serum as Supplements for Cell Culture, Expansion, and Cryopreservation.

Duarte Rojas J, Restrepo Munera L, Estrada Mira S Biomedicines. 2024; 12(1).

PMID: 38255245 PMC: 10813006. DOI: 10.3390/biomedicines12010140.

Evaluation of Osteogenic Potential for Rat Adipose-Derived Stem Cells under Xeno-Free Environment.

Sun Y, Jo J, Hashimoto Y Int J Mol Sci. 2023; 24(24).

PMID: 38139360 PMC: 10744054. DOI: 10.3390/ijms242417532.

References

Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E . Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007; 47(8):1436-46. DOI: 10.1111/j.1537-2995.2007.01220.x. View

Martinez-Zapata M, Marti-Carvajal A, Sola I, Bolibar I, Exposito J, Rodriguez L . Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion. 2008; 49(1):44-56. DOI: 10.1111/j.1537-2995.2008.01945.x. View

Lange C, Cakiroglu F, Spiess A, Cappallo-Obermann H, Dierlamm J, Zander A . Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007; 213(1):18-26. DOI: 10.1002/jcp.21081. View

Bernardo M, Avanzini M, Perotti C, Cometa A, Moretta A, Lenta E . Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol. 2006; 211(1):121-30. DOI: 10.1002/jcp.20911. View

Anitua E, Sanchez M, Orive G, Andia I . The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007; 28(31):4551-60. DOI: 10.1016/j.biomaterials.2007.06.037. View

Kocaoemer A, Kern S, Kluter H, Bieback K . Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007; 25(5):1270-8. DOI: 10.1634/stemcells.2006-0627. View

Reinisch A, Bartmann C, Rohde E, Schallmoser K, Bjelic-Radisic V, Lanzer G . Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med. 2007; 2(4):371-82. DOI: 10.2217/17460751.2.4.371. View

Seghatchian J, Krailadsiri P . The platelet storage lesion. Transfus Med Rev. 1997; 11(2):130-44. DOI: 10.1053/tm.1997.0110130. View

Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D . Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009; 27(9):2331-41. DOI: 10.1002/stem.139. View

10.

Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C . Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods. 2008; 14(3):185-96. DOI: 10.1089/ten.tec.2008.0060. View

11.

Nurden A, Nurden P, Sanchez M, Andia I, Anitua E . Platelets and wound healing. Front Biosci. 2008; 13:3532-48. DOI: 10.2741/2947. View

12.

Tonti G, Mannello F . From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?. Int J Dev Biol. 2008; 52(8):1023-32. DOI: 10.1387/ijdb.082725gt. View

13.

Frechette J, Martineau I, Gagnon G . Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res. 2005; 84(5):434-9. DOI: 10.1177/154405910508400507. View

14.

Carrancio S, Lopez-Holgado N, Sanchez-Guijo F, Villaron E, Barbado V, Tabera S . Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008; 36(8):1014-21. DOI: 10.1016/j.exphem.2008.03.012. View

15.

Selvaggi T, Walker R, Fleisher T . Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood. 1997; 89(3):776-9. View

16.

Weibrich G, Kleis W, Hafner G, Hitzler W . Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg. 2002; 30(2):97-102. DOI: 10.1054/jcms.2002.0285. View

17.

Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo F, Kusumoto K . Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008; 122(5):1352-1360. DOI: 10.1097/PRS.0b013e3181882046. View

18.

Barrientos S, Stojadinovic O, Golinko M, Brem H, Tomic-Canic M . Growth factors and cytokines in wound healing. Wound Repair Regen. 2009; 16(5):585-601. DOI: 10.1111/j.1524-475X.2008.00410.x. View

19.

Reinisch A, Hofmann N, Obenauf A, Kashofer K, Rohde E, Schallmoser K . Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood. 2009; 113(26):6716-25. PMC: 2710924. DOI: 10.1182/blood-2008-09-181362. View

20.

Muller A, Davenport M, Verrier S, Droeser R, Alini M, Bocelli-Tyndall C . Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. Tissue Eng Part A. 2009; 15(4):869-75. DOI: 10.1089/ten.tea.2008.0498. View